Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
| Stock | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| PBLSParabilis Medicines, Inc. | Guy Levy10% Owner | $10.0M | New stake | |||
| Bought 500,000 shares at $20.00 (IPO price, June 11, 2026). Late Form 4 filing — 18 days after trade date, coinciding with IPO lock-up window. Stock now at $27.37 (+36.9% since buy). RA Capital also reported a ~$423M purchase in the same Form 6-K/13D cluster. Fresh IPO on June 10, 2026. | ||||||
| COE51Talk Online Education Group | Jack Jiajia HuangCEO | $3.25M | Added | |||
| Bought 210,000 ADS at weighted avg ~$15.46 on June 24, 2026 via affiliate HH Talent Limited under Rule 10b5-1 plan. Form 6-K filed June 30. Stock now $15.95 (+3.2% since buy). CEO has made 71 purchases totalling ~$92.4M in past 6 months — highest conviction buyer on this list by frequency. | ||||||
| SBSWSibanye Stillwater Ltd | Charl KeyterCFO | $448K | Added | |||
| Bought 200,000 ordinary shares at ZAR 36.80/share (~$2.24/ordinary = ~$8.96/ADS). ADS now at $8.49 (-5.3% since buy). Third open-market purchase in 2026 (prior: 35K shares at $2.70 in March; 148,819 at $11.63). Gold/platinum mining CFO buying into own company amid restructuring — value-conviction signal. | ||||||
Scanned the last 24–48 hours of EDGAR Form 4 filings (filed June 29–30, 2026). 3 qualifying buys (≥ $250K, transaction type P) totalling $13.7M.
⚠️ Data note: EDGAR direct API and all major aggregators (OpenInsider, GuruFocus, Finviz, MarketBeat) returned 403 blocked responses in this session. Data was sourced from web-search snippets, QuiverQuant aggregation, and financial news outlets. July 1 intraday filings may be incomplete — only filings indexed by search engines as of scan time are captured.
PBLS (Parabilis Medicines): Fresh biotech IPO (June 10, 2026). Guy Levy's 500K-share buy at the $20 IPO price was filed as a late Form 4 on June 29 (18 days post-trade). Also notable: RA Capital Management purchased ~21.2M shares at $20 (≈ $423M) via Schedule 13D on June 11 — a massive post-IPO institutional validation, filed June 29. Stock is already up 37% from IPO. Cluster activity: multiple insiders and institutional players scooped up shares at IPO.
COE (51Talk Online Education Group): CEO Jack Jiajia Huang has been an extraordinarily persistent open-market buyer — 71 purchases totalling ~$92.4M in the past six months, all under a Rule 10b5-1 plan via affiliate HH Talent Limited. While plan-driven purchases are less informative than discretionary buys, the scale of conviction ($92M committed personally) is striking for a small-cap Chinese online education company with a $15/ADS stock.
SBSW (Sibanye Stillwater): CFO Charl Keyter's 200K-share open-market buy in the company's own ordinary shares (JSE-listed) at ZAR 36.80, disclosed via SEC Form 6-K on June 30. This is his third purchase in 2026 (prior buys: 35,000 shares at $2.70 in March; 148,819 shares at $11.63). Metals mining company — gold and platinum-group metals — currently navigating a restructuring. CFO purchasing personal capital at current depressed levels is a classic value-conviction signal.
Sector themes: Healthcare/biotech (fresh IPO cluster), Chinese EdTech (relentless CEO buying), and precious metals mining (CFO conviction buy at cyclical lows).
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.